BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

16+ results
Field: Esophageal Cancer Research and Treatment

Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study

Verified

Seema A. Bhat, Helen G. Coleman, Foad Yousef, B. T. Johnston et al.

Journal: JNCI Journal of the National Cancer Institute
Year: 2011
Citations: 742

BACKGROUND: Barrett's esophagus (BE) is a premalignant lesion that predisposes to esophageal adenocarcinoma. However, the reported incidence of esophageal adenocarcinoma in patients with BE varies widely. We examined the risk of malignant progression in patients with BE using data from the Northern ...

Health SciencesMedicineSurgeryOpen Access
Read Source

A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP Diet and Health Study

Verified

Mark G. O’Doherty, Neal D. Freedman, Albert R. Hollenbeck, Arthur Schatzkin et al.

Journal: GutYear: 2011Citations: 160

OBJECTIVE: The incidence of oesophageal adenocarcinoma (EAC) has increased rapidly over the past 40 years and accumulating evidence suggests that obesity, as measured by body mass index (BMI), is a major risk factor. It remains unclear whether abdominal obesity is associated with EAC and gastric ade...

Health SciencesMedicineSurgery
Read Source

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Verified

Paolo Bossi, Salvatore Lo Vullo, Marco Guzzo, Luigi Mariani et al.

Journal: Annals of OncologyYear: 2014Citations: 133

Background Data on preoperative chemotherapy in resectable oral cavity cancer are conflicting. We present the long-term results of a randomized trial of induction chemotherapy in resectable oral cavity cancer. Patients and methods A randomized, parallel, multicentre trial evaluated the impact of thr...

Health SciencesMedicineOtorhinolaryngology
Read Source

Dysbiosis of gut microbiota in patients with esophageal cancer

Verified

YaLi Deng, Derong Tang, Pan‐Fei Hou, Weitao Shen et al.

Journal: Microbial PathogenesisYear: 2020Citations: 129

A number of studies have identified that gut microbiota influences the development of cancer. However, there is little known about gut microbiota and esophageal cancer (EC). The aim of this study was to investigate the gut microbiota profile associated with EC. In this study, 23 patients with EC and...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular Biology
Read Source

Preoperative radiation therapy for carcinoma of the esophagus

Verified

Richard D. Marks, Hugh J. Scruggs, Keene M. Wallace

Journal: CancerYear: 1976Citations: 114

From 1960 through 1973, 415 patients with carcinoma of the esophagus were treated with radiation therapy. Three hundred and thirty-two patients had planned preoperative irradiation to a dose of 4500 rads in 18 fractions, and 101 of these had subsequent resections with either colon or stomach replace...

Health SciencesMedicineSurgeryOpen Access
Read Source

Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus

Verified

Claire Palles, Laura Chegwidden, Xinzhong Li, John M. Findlay et al.

Journal: GastroenterologyYear: 2014Citations: 111

BACKGROUND & AIMS: Barrett's esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found the risk to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome 6p21 (within the HLA region) and on 16q23, where the closest protein-coding gene is FOXF1. Subse...

Health SciencesMedicineSurgeryOpen Access
Read Source

Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer

Verified

Merrill S. Kies, Steven T. Rosen, Tat-Kin Tsang, Ramananda M. Shetty et al.

Journal: CancerYear: 1987Citations: 108

A combined treatment program consisting of chemotherapy with cisplatin and infusion 5-fluorouracil (5-FU) for three cycles followed by esophagectomy or radiation, or both, has been conducted in 26 patients with squamous cancer of the esophagus localized to the primary site. Eleven patients had objec...

Health SciencesMedicineSurgeryOpen Access
Read Source

The incidence and mortality of esophageal cancer and their relationship to development in Asia.

Verified

Reza Pakzad, Abdollah Mohammadian-Hafshejani, Bahman Khosravi, Shahin Soltani et al.

Journal: PubMedYear: 2016Citations: 100

BACKGROUND: Esophageal cancer is the most common cancer in less developed countries. It is necessary to understand epidemiology of the cancer for planning. The aim of this study was to evaluate the incidence and mortality of esophageal cancer, and its relationship with Human Development Index (HDI) ...

Health SciencesMedicineSurgeryOpen Access
Read Source

Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial

Verified

Debasish Das, Savid Ishaq, Rebecca Harrison, Kiran Kosuri et al.

Journal: The American Journal of GastroenterologyYear: 2008Citations: 100

OBJECTIVES: To assess the variation in practice of Barrett's esophagus (BE) management in comparison with accepted international guidelines before and after the introduction of a large BE randomized controlled trial (RCT) with protocols including those of tissue sampling. DESIGN: A validated anonymi...

Health SciencesMedicineSurgery
Read Source

Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia

Verified

CM Gleeson, JM Sloan, DT McManus, Perry Maxwell et al.

Journal: British Journal of CancerYear: 1998Citations: 96

This study examined the association between 17p allelic loss, p53 gene mutation, p53 protein expression and DNA aneuploidy in a series of adenocarcinomas arising in the oesophagus and gastric cardia. 17p allelic loss was detected in 79% (15 of 19) of oesophageal and in 83% (29 of 35) of gastric aden...

Health SciencesMedicineSurgeryOpen Access
Read Source

A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer

Verified

Jonathan Shenfine, Paul McNamee, Nick Steen, J Bond et al.

Journal: Health Technology AssessmentYear: 2005Citations: 89

OBJECTIVES: To compare whether treatment with self-expanding metal stents (SEMS) is more cost-effective than treatment with conventional modalities in patients with inoperable oesophageal cancer. Quality of life effects were also considered. DESIGN: A multicentre pragmatic, randomised controlled tri...

Health SciencesMedicineSurgeryOpen Access
Read Source

A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma

Verified

Hong Fan, Dongsheng Liu, Xuemei Qiu, Fengchang Qiao et al.

Journal: BMC MedicineYear: 2010Citations: 88

BACKGROUND: DNA-methyltransferase (DNMT)-3A plays an important role in the development of embryogenesis and the generation of aberrant methylation in carcinogenesis. The aim of this study was to investigate the role of a DNMT3A promoter genetic variant on its transcriptional activity and to evaluate...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

ELNet:Automatic classification and segmentation for esophageal lesions using convolutional neural network

Verified

Zhan Wu, Rongjun Ge, Minli Wen, Gaoshuang Liu et al.

Journal: Medical Image AnalysisYear: 2020Citations: 78

Automatic and accurate esophageal lesion classification and segmentation is of great significance to clinically estimate the lesion statuses of the esophageal diseases and make suitable diagnostic schemes. Due to individual variations and visual similarities of lesions in shapes, colors, and texture...

Health SciencesMedicineSurgery
Read Source

Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma

Verified

Mark G. O’Doherty, Marie M. Cantwell, Liam Murray, Lesley Anderson et al.

Journal: International Journal of CancerYear: 2011Citations: 71

The aim of our study was to investigate whether dietary fat and meat intakes are associated with reflux esophagitis (RE), Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC). In this all-Ireland case-control study, dietary intake data were collected using a food frequency questionnaire in 2...

Health SciencesMedicineSurgeryOpen Access
Read Source

First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: <scp>CheckMate</scp> 649 Chinese subgroup analysis

Verified

Tianshu Liu, Yuxian Bai, Xiaoyan Lin, Wěi Li et al.

Journal: International Journal of CancerYear: 2022Citations: 70

First-line chemotherapy for advanced/metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric/gastroesophageal junction cancer (GC/GEJC) has poor median overall survival (OS; <1 year). We report efficacy and safety results from Chinese patients in the phase III global CheckMate 64...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source
PreviousPage 1 of 2+Next